Work

Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients

Year: 2017

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-017-3258-0

Authors: D. Mahadevan, Monica Mita, Donald Richards, Edward McClay, Rebecca Suk Heist, A. Kumar, S. Sundararajan, Aung Naing

Institutions: University of Arizona Cancer Center, Cedars-Sinai Medical Center, Texas Oncology, California Cancer Associates for Research and Excellence, Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: EMD Serono

OpenAlex ID: W2596027969

FWCI: 0.762

Cites: 20

Cited by: 5

Related to: 10